Augmented Intelligence in Skin Cancer Detection and Prognosis

At Fall Clinical 2026 in Las Vegas, Nevada, Shannon Trotter, DO, a board-certified dermatologist with DOCS Dermatology in Central Ohio and a clinical assistant professor at Ohio University, discussed the role of augmented intelligence in skin cancer detection and prognosis. She also highlighted the approval of remibrutinib for symptomatic dermatographism and shared how her podcast supports patient and provider education.

Augmented Intelligence in Skin Cancer Detection and Prognosis

Trotter said she is most looking forward to the application of artificial intelligence, or augmented intelligence, in non-melanoma skin cancer and melanoma. The approach combines AI with the clinician to provide good outcomes for patients. She noted new products on the market are improving diagnostic skills and creating an opportunity to detect skin cancer much earlier.

Gene expression profiling, alone or combined with AI, now allows clinicians to offer prognostic information to patients, according to Trotter. She expects this to help therapeutically in the future as well.

“A lot of people think of AI as a foe, but it’s definitely a friend for skin cancer,” Trotter said.

Remibrutinib Approval for Symptomatic Dermatographism

Trotter pointed to the approval of remibrutinib for symptomatic dermatographism, a type of chronic inducible urticaria, as a late-breaking development. She described the condition as very challenging to treat, with limited access to medications previously.

“With this approval, I think we’re going to have an exciting option for patients to give them more control over their disease,” Trotter said.

Patient and Provider Education Through Podcasting

Trotter called her podcast, “Derm-it Trotter. Don’t Swear About Skincare,” her passion project. The show is dedicated to patient education on all things skin, and healthcare providers listen as well. For patients, it offers accurate, honest, and simplified information about dermatology.

For clinicians, the podcast serves a different purpose.

“For the healthcare provider, it’s helping you distill topics down so you can explain it better to your patient and also glean some clinical pearls,” Trotter said.

She encouraged providers whose patients ask where to find accurate information to direct them to the podcast. It is available on all streaming services and YouTube, with more information at www.drtrotter.com.

What Sets Fall Clinical Apart

Trotter said the meeting offers the best of what dermatology has to offer, including amazing faculty, salient clinical pearls, and fun. Attendees reunite with colleagues, see friends, and socialize.

“This is really the complete package where you get all the information, but it doesn’t seem like work,” Trotter said. In her view, the combination puts dermatology on a different level.

Stay tuned for Trotter’s part 2 interview on session highlights on cutaneous squamous cell carcinoma.